Pharmacology & ToxicologyInternational Journal of Molecular SciencesPeer-reviewed
Towards new AQP4 inhibitors: ORI-TRN-002
M. Thormann, N. Traube, N. Yehia…·T. L. Toft-Bertelsen
This paper identifies ORI-TRN-002 as a novel AQP4 inhibitor with improved solubility and low protein binding, potentially useful for antiedema therapy.
DOI 10.3390/ijms25020924